I also have concerns about the COCID trial.
As with the HIV trials, I suspect they will only delive some positive aspects to fighting COVID and not a knockout blow.
BIT prioritised the HIV results - as they should have - but I also wonder if BIT knew the COVID results were not that exceptional.
Release of the COVID results may have the same effect as the release of the HIV results - investors may only see a long road ahead rather than an immediate reward.
Ann: Application for quotation of securities - BIT, page-21
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
